The synthesis and characterization of a copper complex with glimepiride (an oral antidiabetic drug) has been studied. The conductometric titration using monovariation method indicates that complex is non-ionic and of ML 2 type.Analytical data agrees with the molecular formula (C 24 H 34 N 4 O 5 S) 2 Cu. Structure of the complex was assigned as square planar in which ligand molecules lies horizontally joining the central copper atom. Infrared, Mass spectral and particle size analysis had confirm the co-ordination of sulphonyl oxygen on one side and enolic oxygen attached from other side with the metal ion. The structure for complex was proposed on the basis of analytical data and elemental analysis.
Glimepiride 1-(p-(2-(3-ethyle-4-methyl-2-oxo-3-pyroline-1-carboxamido)ethyl)phenyl sulfonyl)-3-(trans-4-methylcyclohexyl) Urea is a third generation hypoglycemic sulfonylurea, which is useful in the treatment of non-insulin dependent diabetes mellitus (NIDDM) 1-2 . Glimepiride is a white crystalline powder, relatively insoluble in water. It exhibits slow gastrointestinal absorption rate and inter individual variation of its bioavailability.
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The slow absorption rate of drug usually originates from either poor dissolution of drug from the formulation or poor permeability of drug across gastrointestinal membrane. For poorly water soluble and highly permeable drugs the rate of oral absorption is often controlled by the dissolution rate in the gastrontestinal tract 4 . Complexation of sulfonylurea with lighter transition metal has been studied in detail by Yoshinaga and Yamamotto (1966) 5 , Qureshi and Iqbal (1985) 6 . A persual of available literature shows that systemic study on complexation of copper with sulphonyl ureas is relatively scanty. [7] [8] [9] [10] The study of chemistry and chemical reaction of structure co-ordination compound helps in establishing structure activity relationship. It has been reported that in biological activity metal complex is more potent and less toxic as compared to the free ligand 11 . In view of the above and in continuation of our work, It is interesting to have an insight into the synthesis of copper complex with glimepiride and to diagnose various structural aspects of the isolated complex.
Here the synthesis and characterization of cupric chloride with glimepiride has been described.
Ligand-metal ratio
To confirm the ligand metal ratio, conductometric titrations using monovariation method were carried out at 27± 1 0 C 0.005M solution of glimepiride drug was prepared in 80:20 mixture of DMF and water. Similarly solution of metal salt CuCl 2 .2H 2 O was prepared in the same solvent of 0.01M concentration. 20mL of ligand was diluted to 200ml with the same solvent. The ligand was titrated against metal salt solution using monovariation method. Conductance was recorded after each addition, Graph is plotted between corrected conductance and volume of metal salt added (Fig II) . From the equivalence point in the graph it has been concluded that the complex formation has taken place in the ratio of 2:1 (L:M). Stability constant and free energy changes were also calculated using Job's method 12 of continuous variation (Fig. 3) . IR spectra of ligands and complexes were recorded with perkin Elmer spectrometer in the range of 4000-450 cm -1 (CDRI Lucknow, India). Mass spectral results of ligand and complex were obtained from CDRI Lucknow while Electronic spectral studies were carried out on a Lambda 25 instrument model at 480 nm/min scan speed from Sadhu Vaswani College, Bhopal.
Synthesis
Complex was synthesized by mixing the solution (80% DMF) metal salt solutions with that of ligand in 1:2 molar ratios; respectively at room temperature maintaining the pH between (6.5-8) by the addition of dilute NaOH solution. On refluxing the mixture content for 3hrs at 80 0 C and on cooling the Harbour blue crystals of glimepiridecopper complex were obtained. [13] [14] [15] [16] [17] The complex was washed with 80% DMF or alcohol and weighed (yield-70%). 
RESULTS AND DISCUSSION
The synthesized complex is blue and stable, being soluble in DMSO, acetone and insoluble in water, ethanol etc. Analytical data (table 4) and conductometric studies suggest 2:1 (L:M) ratio. Measured conductance values of these complex are too low to account for their electrolytic behaviour.
Structure Determination IR absorption studies
The IR spectrum [18] [19] [20] [21] of the ligand and the isolated complex were scanned in the range 4000-450 cm -1 and the probable assignments are given in (table 5) . The proposed structure for the isolated complex is also supported by IR absorption bands and characterized by the absorption of carbonyl (C=O) and sulphonyl urea group at 1700 cm -1 and 1216 cm -1 respectively. The NH group observed at 3681 cm -1 in the ligand (glimepiride) was shifted to 3758 cm -1 in copper glimepiride complex. The next IR band of structural significance of the ligand appears at 1017 cm -1 which may be assigned to u (C-O), which was absent in pure ligand and the considerable frequency of υ (C=N) was obtained at 1540 cm -1 in metal complex while absent in pure ligand were indicates that these specific IR absorptions are appeared due to complexation. The linkage through amide-O and sulphone -O-atom was further supported by the appearance of a band in the far IR region at 671 cm -1 in the complex that may be assignable to M-O frequency (Fig IV a&b) . Table 5 . IR Absorption data of the complex in cm The mass spectrum of the pure ligand shows a molecular ion peak m at m/z 491 due to (C 24 H 34 N 4 O 5 S) parent ion peak 22 which is in accordance with the proposed formula of the ligand. The other peak of appreciable intensity has been observed at m/z value 352 correspond to species (C 17 H 16 N 3 O 4 S) due to loss of (C 7 H 18 NO) fragment radical cation having a molecular mass 132. While the mass spectrum of [Cu(C 24 H 34 N 4 O 5 S) 2 ] shows a molecular ion peak m at 1044 which corresponds to molecular weight of complex supported for the monomeric structure [23] [24] . Beside this peak the complex showed the fragment ion peak at m/z 972 due to (L 2 ) radical cation. The peaks of appreciable intensity have been observed at m/ z values 149, 253, 315, 329, 413, 485, 527, 591, 605, 665, 666, 696, 803, 869, 972 and 1044 which indicate the fragmentation pattern. The peak observed at m/z 972 due to (L 2 ) . The complex showed the fragment ion peak at m/z 803 due to species (C 42 H 57 N 7 O 7 S) . The peaks of appreciable intensity has been observed at m/z value 253 due to (C 12 H 17 N 2 O 2 S) base peak.
Fig. 4(a). IR Spectra of Pure Drug Glimepiride

Fig. 4(b). IR Spectra of Glimepiride-Copper complex
Some important mass spectral intensities of metal complex of Glimepiride are summarised in table.
Electronic spectral studies of the complex
Electronic spectra offer great help in determining the structure of metal complexes. Electronic spectra of transition metal ions and complexes are obtained in the visible and ultraviolet region. [25] [26] In the present study the above spectra for the complex were obtained from Sadhu Vaswani College, Bhopal and the analysis were carried out on a Lambda 25 instrument model at 480 nm/min scan speed.
The observed electronic spectral bands of the glimepiride ligand and metal complex (copperglimepiride) are given in table (7) as follows :- 
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Antidiabetic activity of glimepiride copper complex
This isolated glimepiride-metal complex were found to be more potent as compared th the parent drug. Hence as compare to standard synthetic drug the glimepiride-copper complex 31 was having more hypoglycemic activity. The hypoglycemic effect of glimepiride as well as metal complex were investigated on the blood sugar levels of male wistar rats by alloxan induced antidiabetic test (PBRI, Lab Bhopal, India). Analysis of data presented in (table 8) reveals that the drug caused a marked decrease in blood sugar level. On comparing the hypoglycemic effect of copper comple with parent drug it was revealed that in case of Cu-glimepiride treated male wistar rats blood sugar falls to 90.8±1.9235 mg/dl while in glimepiride treated rats blood sugar falls to .961.5811 mg/dl. These results clearly indicate a better hypoglycemic activity of Cu-glimepiride complex over its parent drug. Blood-sugar level after 3 hr.
Blood-sugar level after 6 hr. Hypoglycemic activities of the complex shows more blood sugar lowering effect as compared to parent ligand. Calculating the toxicity in the complexes and on many trials on monkey's and men the complex may be introduced as medicine in future.
